{"pub_date": "2016-08-12T04:00:00+0000", "subsection_name": null, "lead_paragraph": "The agency decided not to reclassify marijuana from a Schedule 1 drug to a Schedule 2 drug, but removed a roadblock to medical studies of marijuana.", "print_page": "13", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "LOUIS", "firstname": "Catherine", "role": "reported", "middlename": "Saint"}], "original": "By CATHERINE SAINT LOUIS"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 400, "url": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/08/12/science/12MARIJUANA/12MARIJUANA-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Health", "headline": {"print_headline": "D.E.A. Refusal to Reclassify Marijuana Draws Criticism", "main": "D.E.A. Keeps Marijuana on List of Dangerous Drugs, Frustrating Advocates"}, "source": "The New York Times", "blog": [], "word_count": "910", "web_url": "http://www.nytimes.com/2016/08/12/health/dea-keeps-marijuana-on-list-of-dangerous-drugs-frustrating-advocates.html", "slideshow_credits": null, "news_desk": "National", "type_of_material": "News", "snippet": "The agency decided not to reclassify marijuana from a Schedule 1 drug to a Schedule 2 drug, but removed a roadblock to medical studies of marijuana....", "_id": "57ad251b95d0e021d79803dd", "abstract": "Drug Enforcement Agency refuses to reclassify marijuana from Schedule 1 drug to Schedule 2 drug, move that would remove it from list of nation's most dangerous drugs and ease research and medical use; decision angers scientists, public officials and advocates, although DEA says it will allow universities and private companies to apply to grow marijuana for research.", "keywords": [{"rank": "1", "name": "subject", "value": "Medical Marijuana", "is_major": "N"}, {"rank": "2", "name": "subject", "value": "Marijuana", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Drug Abuse and Traffic", "is_major": "N"}, {"rank": "4", "name": "subject", "value": "United States Politics and Government", "is_major": "N"}, {"rank": "5", "name": "organizations", "value": "Drug Enforcement Administration", "is_major": "Y"}, {"rank": "6", "name": "subject", "value": "Research", "is_major": "N"}, {"rank": "7", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}]}